|Year : 2017 | Volume
| Issue : 3 | Page : 549-553
Depression and its associated factors among people living with HIV/AIDS: Can it affect their quality of life?
Namita Navanit Deshmukh1, Avinash M Borkar1, Jyotsna S Deshmukh2
1 Assistant Professor, Department of Community Medicine, Late Shri Lakhi Ram Agrawal Memorial Government Medical College, Raigarh, Chhattisgarh, India
2 Associate Professor, Department of Community Medicine, Indira Gandhi Government Medical College, Nagpur, Maharashtra, India
|Date of Web Publication||29-Dec-2017|
Dr. Namita Navanit Deshmukh
C/O Prof. Navanit S. Deshmukh, Suyog Prakashan, Near Jijamata Primary School, Nagpur Road, Wardha - 442 001, Maharashtra
Source of Support: None, Conflict of Interest: None
Introduction: Depression, being the most common neuropsychiatric complication of HIV, is also associated with increased health-care utilization, decreased quality of life (QOL), and poor adherence to antiretroviral therapy (ART). Depression is a multidimensional disorder affected by a variety of biological, psychological, and social determinants and this relation becomes more complicated in HIV patients. The current study therefore aimed to investigate the sociodemographic and clinical determinants of depression and assess difference in the QOL of HIV patients not having depression and those suffering from depression. Materials and Methods: A cross-sectional study was conducted at an ART center in a tertiary care hospital in HIV/AIDS patients of 18 years of age. Sociodemographic and clinical characteristics were studied, depression anxiety and stress scale-21 was used to assess depression, and QOL assessment was done using WHOQOL-HIV BREF questionnaire. Results and Conclusions: Out of 754 study subjects, 377, i.e., 50% suffered from depression and nearly 75.9% of them were in the age group of 25–44 years. The prevalence of depression was higher in females, illiterates, and unemployed HIV patients as compared to males, literates, and employed subjects, respectively. HIV patients who were depressed had significantly lower QOL than the subjects not suffering from depression, more so in the environment and social relationships domains.
Keywords: Depression, depression anxiety and stress scale, HIV/AIDS, quality of life, WHO Quality of Life BREF scale
|How to cite this article:|
Deshmukh NN, Borkar AM, Deshmukh JS. Depression and its associated factors among people living with HIV/AIDS: Can it affect their quality of life?. J Family Med Prim Care 2017;6:549-53
|How to cite this URL:|
Deshmukh NN, Borkar AM, Deshmukh JS. Depression and its associated factors among people living with HIV/AIDS: Can it affect their quality of life?. J Family Med Prim Care [serial online] 2017 [cited 2020 Jul 3];6:549-53. Available from: http://www.jfmpc.com/text.asp?2017/6/3/549/222016
| Introduction|| |
India is estimated to have the third highest number of people living with HIV/AIDS, after South Africa and Nigeria which accounts to 20.89 lakh population. Depression being the most common neuropsychiatric complication of HIV disease, its prevalence varies from 22% to 71%. Still it remains underdiagnosed. Discovery of infection has a dramatic psychological impact on the patients and even the virus itself being neurotropic, produces neuropathological changes in the gray matter and can lead to depression. Depression is associated with increased health-care utilization, decreased quality of life (QOL), and increased suicidal rate among patients with HIV. Moreover, depression increases the likelihood of HIV transmission, is associated with poor adherence to antiretroviral therapy (ART) leading to immunological failure, and may independently increase HIV progression. It is therefore crucial to identify patients with depression for proper management of the disease.
The sociodemographic factors of age, gender, marital status, education, and income are important factors, in explaining the variability in depression prevalence rates. The current study therefore aimed to investigate
- the sociodemographic and clinical determinants of depression
- difference in the QOL of HIV patients not having depression and those suffering from depression.
| Materials and Methods|| |
Approval from the Institutional Ethics Committee was sought before commencing the study and written informed consent of each study participant was taken before starting the interview.
Study design and study setting
This study was conducted at an ART center in a tertiary care hospital, located in central India. This ART center was established in December 2008, and totally 1181 HIV/AIDS patients were registered there before the start of the study. The current cross-sectional study was carried out during January 2011–January 2012.
Study population and sampling
The target population was HIV/AIDS patients of 18 years of age and above and on ART for the past 6 months. First, 6 months of ART are critical. Some patients may not respond as expected or may even deteriorate clinically at first. This would have adversely affected the current study, hence, patients on ART for 6 months and more were considered eligible for the study. Critically ill, patients with behavioral disorders and those who did not consent were excluded from the study.
Instruments and measures
- Sociodemographic and clinical characteristics studied were age, sex, education, employment status, marital status, place of residence, presence of symptoms of opportunistic infections, CD4 cell counts, and body mass index (BMI)
- Screening for depression: This was done using depression anxiety and stress scale-21 (DASS-21) which is a short version of DASS-42 and was developed by S. H. Lovibond and P. F. Lovibond, 1995.,, Internal consistency reliability coefficient alphas for Depression, Anxiety, Stress subscales, and full Scale (DASS-21) were 0.88, 0.82, 0.90, and 0.93, respectively. This shows that the scale items were homogenous. The scale also had moderate discriminant validity (P < 0.001), i.e., the scale was able to distinguish between ill and well subjects.,, Scores more than nine were indicative of depression and below nine were considered normal
- Quality of life assessment: This was done using WHOQOL-HIV BREF questionnaire., It has 31 questions grouped under six domains such as physical domain, psychological domain, independence domain, social relationships domain, environmental domain, and personal beliefs domain. The instrument uses a five-point-interval response-Likert-scale where higher scores indicate better QOL. Domain-wise and total scores were calculated as per the guidelines. According to the WHO, Cronbach's alpha values for each of the domain scores ranged from 0.66 (for domain three) to 0.84 (for domain one), demonstrating good internal consistency. Test-retest reliability using Pearson r correlation test-ranged from 0.68 to 0.95 and the instrument discriminated well between ill and well (using t-test - P < 0.01) showing good discriminant validity.
STATA 10.1 version (StataCorp. 2007. Stata Statistical Software: Release 10. College Station, TX: StataCorp LP.) was used for statistical analysis. Categorical variables were measured using their frequencies and percentages. Odds ratios (OR) with 95% confidence interval (CI) were used to evaluate the factors associated with depressive symptoms. The unadjusted ORs were calculated by univariate logistic regression. Variables with P < 0.25 were included in multiple logistic regression analysis. The criterion for entering and removing the independent variables from the backward stepwise model was P < 0.05. The Hosmer–Lemeshow goodness-of-fit test was applied.
| Results|| |
Depression was dichotomized into two groups, i.e., the categories “mild,” “moderate,” “severe,” and “extremely severe” were merged and renamed “depressed” while the other category was “normal.” Out of 754 study subjects, 377, i.e., 50% suffered from depression and nearly 75.9% of them were in the age group of 25–44 years [Table 1].
|Table 1: Age group-wise prevalence of depression in patients living with HIV/AIDS|
Click here to view
Out of 754 patients, 61% were male and 39% were female. Nearly 12.5% patients were illiterate, 32.8% had no spouse, and 26% were unemployed. Almost 92.6% of depressed HIV patients and 83% of the nondepressed HIV patients belonged to lower socioeconomic class [Table 2].
|Table 2: Unadjusted sociodemographic determinants of depression in HIV patients|
Click here to view
The prevalence of depression was higher in females, illiterates, and unemployed HIV patients as compared to males, literates, and employed subjects, respectively. In addition, they were twice at the risk of suffering from depression. It was also observed that while those who were not having spouse to support were thrice at risk. Depression was significantly more prevalent in patients who belonged to lower socioeconomic class (50.7%) than those who belonged to middle and upper socioeconomic class (30.4%) [Table 2].
Symptomatic patients were those suffering from one or the other opportunistic infections and out of 165 patients, who were symptomatic, 113 (68.5%) were also suffering from depression. Moreover, they were 2.7 times at the risk of suffering from depression than their asymptomatic counterparts. Place of residence (whether residing in rural area or urban area) had no effect on depression in HIV patients. Similarly, CD4 counts did not show any significant difference on the mental state of the patients. This might be because though the CD4 counts seemed lower, they were actually increasing as the patients were on ART. However, nutritional status, as denoted by BMI, had significant difference on the mental state of the HIV patients as out of 343 patients who had BMI <18.5, 255 (74.3%) patients suffered from depression whereas out of 411 patients who had BMI ≥18.5, only 122 (29.7%) patients suffered from depression. It was clear that undernourished patients experienced more depression than the properly nourished ones [Table 2].
All those variables which were found significant in the previous analysis with P < 0.25 were entered in the full model of multiple logistic regression [Table 3]. Stepwise, backward elimination procedure was followed to eliminate nonsignificant variables from the model. Final reduced model included only those variables which were found with P < 0.05 [Table 4].
|Table 3: Multiple logistic regression analysis of depression and sociodemographic and clinical factors affecting depression (full model)|
Click here to view
|Table 4: Multiple logistic regression analysis of Depression and sociodemographic and clinical factors affecting depression (final model)|
Click here to view
QOL assessment showed that QOL of all the HIV patients was poor as all of them scored very low scores in the QOL assessment. However, overall QOL of depressed HIV patients was compromised as denoted by the total QOL score. They scored significantly lower scores in all the six domains of QOL than their nondepressed counterparts. Most affected domains in case of depressed patients were social and environmental domains [Table 5].
|Table 5: Domain-wise quality of life scores in normal and depressed patients|
Click here to view
Lower scores in the social domain indicated that patients were comparatively unhappy with their social relationships, felt dependent, and a bothering to others, were not able to concentrate on their work and were not satisfied with themselves.
Lower scores in the environmental domain indicated that our patients were not satisfied with the conditions of their living places or the physical environment in their locality, had poor financial resources, did not feel safe, felt oppressed, and were unhappy with the transport and access to health care.
| Discussions|| |
Depression and anxiety significantly impair work functioning, social functioning, and health of an individual and his QOL, more so than the patients with congestive heart failure, diabetes, and myocardial infarction. This situation becomes worse if the individual is HIV positive and on ART. ART prolongs the life but morbidities such as depression impair the QOL. Hence, an effort was made in the present study, to find out the correlates of depression and compare the QOL of HIV patients who had depression and those who had no depression.
In the current study, depression was seen in 50% of the patients. Shacham et al. reported that 43% of their subjects suffered from depression (major depression + other depressive disorders) which was quite close to our observations. With univariate analysis, depression was found more prevalent in females than males, as is also seen in general population. Women having more depression, anxiety, and stress were also reported by Gordillo et al., Wisniewski et al., Rapaport et al., and Othman et al. Other important correlates found in this study were illiteracy, unemployment, lower socioeconomic status, presence of opportunistic infections, not having life-partner and BMI <18.5 kg/m 2. Similar findings were reported by Shittu et al., Unnikrishnan et al., and Ibrahim et al. Income is the most significant social determinant of health because it determines one's overall living conditions, affect one's psychological condition, and help shape one's diet and eating habits. Low-income people living in poverty, cannot afford healthy food, sufficient clothing and good housing all of which are necessary preconditions of good health. Similarly, low social support causes more stress and can accelerate the progression from HIV to AIDS.
Poor QOL can be a consequence of depression as well as its precursor. Regardless of the interrelationship, there have been very few attempts to conduct research to understand the relationship between QOL and depression. The three-dimensional theory developed by de Leval situates both depression and QOL as part of a continuum in time rather than as independent phenomena. The greater the gap between past and present, the greater the depression and poorer the QOL. Many a times, QOL impairments associated with depression are equal to or greater than those seen with other chronic disorders. In the present study, patients who were depressed had significantly lower QOL than the subjects not suffering from depression more so in the environment and social relationships domains. Similar findings were reported by Campos et al., who found that patients who lacked or had mild symptoms of depression had 4.91 times higher chances of having good QOL as compared to those having severe depression (OR 4.91, 95% CI - 1.85–12.98, P = 0.001).
| Conclusions|| |
The prevalence of depression was higher in HIV patients in our study and its important correlates were illiteracy, unemployment, lower socioeconomic status, presence of opportunistic infections, not having life partner, and BMI <18.5 kg/m 2. In addition, patients suffering from depression had poor QOL than those HIV patients who did not have depression. This indicates the dire need to incorporate mental health care including screening and management of depression, in the HIV care guidelines as its prevalence is as high as those of other HIV associated conditions such as tuberculosis and hepatitis B infection. Routine screening of this more common psychiatric condition among HIV positive subjects should be practiced to optimize patient care and improve clinical outcomes. Given the availability of effective pharmacological and psychotherapeutic interventions for depression, neglect of this aspect of care for persons with HIV infection is reprehensible.
Our study did have certain limitations. Since it was a cross-sectional study, the issue of temporality is a barrier in understanding the association of various factors such as low BMI and physical ailments with depression. Whether depression preceded or succeeded these factors is difficult to delineate. Ours was a quantitative enquiry to assess depression levels in HIV patients. Along with quantitative design, qualitative approach like focus group discussions and in-depth interviews would have put forth some more facts of the disease.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
National AIDS Control Organisation, Department of AIDS Control. Annual Report 2013-2014. New Delhi: Ministry of Health and Family Welfare, Government of India; 2014. p. 9-12.
Campos LN, Guimarães MD, Remien RH. Anxiety and depression symptoms as risk factors for non-adherence to antiretroviral therapy in Brazil. AIDS Behav 2010;14:289-99.
Ibrahim AW, Jidda MS, Wakil MA, Rabbebe IB, Omeiza AB, Yusuph H. Prevalence, correlates and under-diagnosis of clinical depression among adults on highly active anti retroviral therapy in a tertiary health institution in Northeastern Nigeria. J Public Health Afr 2014;5:93-8.
L'akoa RM, Noubiap JJ, Fang Y, Ntone FE, Kuaban C. Prevalence and correlates of depressive symptoms in HIV-positive patients: A cross-sectional study among newly diagnosed patients in Yaoundé, Cameroon. BMC Psychiatry 2013;13:228.
Shittu RO, Issa BA, Olanrewaju GT, Mahmoud AO, Odeigah LO, Salami AK, et al
. Prevalence and correlates of depressive disorders among people living with HIV/AIDS, in North Central Nigeria. J AIDS Clin Res 2013;4:251.
National AIDS Control Organization. Antiretroviral Therapy Guidelines for HIV-Infected Adults and Adolescents Including Post-Exposure Prophylaxis. New Delhi: Ministry of Health and Family Welfare, Government of India; 2007. p. 1-25.
Andreou E, Alexopoulos EC, Lionis C, Varvogli L, Gnardellis C, Chrousos GP, et al.
Perceived stress scale: Reliability and validity study in Greece. Int J Environ Res Public Health 2011;8:3287-98.
Henry JD, Crawford JR. The short-form version of the depression anxiety stress scales (DASS-21): Construct validity and normative data in a large non-clinical sample. Br J Clin Psychol 2005;44(Pt 2):227-39.
Imam SS. Depression Anxiety Stress Scales (DASS): Revisited. The 4th
International Postgraduate Research Colloquium. Bangkok, Thailand: IPRC Proceedings;2007:184-96.
HIV/AIDS Quality of Life Group. Scoring and Coding for the WHOQOL-HIV Instruments: Users Manual. Division of Mental Health and Prevention of Substance Abuse. Geneva: World Health Organization; 2002. p. 10-1.
HIV/AIDS Quality of Life Group. WHOQOL User Manual: Draft, Program on Mental Health. Division of Mental Health and Prevention of Substance Abuse. Geneva: World Health Organization; 1998. p. 1-88.
Brenes GA. Anxiety, depression, and quality of life in primary care patients. Prim Care Companion J Clin Psychiatry 2007;9:437-43.
Shacham E, Nurutdinova D, Satyanarayana V, Stamm K, Overton ET. Routine screening for depression: Identifying a challenge for successful HIV care. AIDS Patient Care STDS 2009;23:949-55.
Gordillo V, Fekete E, Platteau T, Antoni MH, Schneiderman N, Nöstlinger C. Emotional support and gender in people living with HIV: Effects on psychological well-being. J Behav Med 2009;32:523-31.
Wisniewski AB, Apel S, Selnes OA, Nath A, McArthur JC, Dobs AS. Depressive symptoms, quality of life, and neuropsychological performance in HIV/AIDS: The impact of gender and injection drug use. J Neurovirol 2005;11:138-43.
Rapaport MH, Clary C, Fayyad R, Endicott J. Quality-of-life impairment in depressive and anxiety disorders. Am J Psychiatry 2005;162:1171-8.
Othman Z, Fadzil NA, Zakaria R, Jaapar SZ, Husain M. Religiosity in Malay patients with HIV? AIDS: Correlation with emotional distress. Middle East J Sci Res 2015;23:170-4.
Unnikrishnan B, Jagannath V, Ramapuram JT, Achappa B, Madi D. Study of depression and its associated factors among women living with HIV/AIDS in Coastal South India. ISRN AIDS 2012;2012:684972.
Moore M, Höfer S, McGee H, Ring L. Can the concepts of depression and quality of life be integrated using a time perspective? Health Qual Life Outcomes 2005;3:1.
Campos LN, César CC, Guimarães MD. Quality of life among HIV-infected patients in Brazil after initiation of treatment. Clinics (Sao Paulo) 2009;64:867-75.
[Table 1], [Table 2], [Table 3], [Table 4], [Table 5]
|This article has been cited by|
||Effectiveness of psychological treatments for depressive symptoms among people living with HIV/AIDS in low- and middle-income countries: A systematic review and meta-analysis
| ||Biksegn Asrat,Marguerite Schneider,Fentie Ambaw,Crick Lund |
| ||Journal of Affective Disorders. 2020; 270: 174 |
|[Pubmed] | [DOI]|
||Suicidal ideation, psychopathology and associated factors among HIV-infected adults in Indonesia
| ||Youdiil Ophinni,Youdiil Adrian,Kristiana Siste,Martina Wiwie,Gina Anindyajati,Enjeline Hanafi,Reza Damayanti,Yoshitake Hayashi |
| ||BMC Psychiatry. 2020; 20(1) |
|[Pubmed] | [DOI]|
||Comparison of Three Health-Related Quality of Life Instruments to Evaluate Symptoms of Depression in HIV Patients in Brazil
| ||Juliet Valdelamar-Jiménez,Liliane Lins-Kusterer,Suzane Tínel Gonzaga de Jesus,Eduardo Martins Netto,Carlos Brites |
| ||Journal of Clinical Psychology in Medical Settings. 2019; |
|[Pubmed] | [DOI]|
||Depression, social support, and stigma as predictors of quality of life over time: results from an Asha-based HIV/AIDS intervention in India
| ||Dana Rose Garfin,Sanghyuk S. Shin,Maria L. Ekstrand,Kartik Yadav,Catherine L. Carpenter,Sanjeev Sinha,Adeline M. Nyamathi |
| ||AIDS Care. 2019; 31(5): 563 |
|[Pubmed] | [DOI]|
||Quality of life, depression and correlates in HIV+ people at An Hoa Clinic, Ho Chi Minh City
| ||Van-Anh N. Huynh,Quyen G. To,Dung V. Do,Mai TH. Nguyen,Kien G. To |
| ||AIDS Care. 2019; 31(5): 582 |
|[Pubmed] | [DOI]|
||Depression among Adult HIV/AIDS Patients Attending ART Clinics at Aksum Town, Aksum, Ethiopia: A Cross-Sectional Study
| ||Berhe Beyene Gebrezgiabher,Teklehaymanot Huluf Abraha,Etsay Hailu,Hailay Siyum,Getachew Mebrahtu,Berihu Gidey,Mebrahtu Abay,Solomon Hintsa,Teklit Angesom |
| ||Depression Research and Treatment. 2019; 2019: 1 |
|[Pubmed] | [DOI]|
||Untreated depression among persons living with human immunodeficiency virus in Kazakhstan: A cross-sectional study
| ||Dina Terloyeva,Zhamilya Nugmanova,Gulzhakhan Akhmetova,Aikan Akanov,Nimish Patel,Victoria Lazariu,Lisa Norelli,Louise-Anne McNutt,Lucette A. Cysique |
| ||PLOS ONE. 2018; 13(3): e0193976 |
|[Pubmed] | [DOI]|
||Prevalence of depression or depressive symptoms among people living with HIV/AIDS in China: a systematic review and meta-analysis
| ||Tingting Wang,Hanlin Fu,Atipatsa Chiwanda Kaminga,Zhanzhan Li,Guiping Guo,Lizhang Chen,Qiongxuan Li |
| ||BMC Psychiatry. 2018; 18(1) |
|[Pubmed] | [DOI]|